Incyte Corporation is trading 5.8% up at $109.20 following positive growth commentary and valuation-focused research updates highlighting strong 2025 results and revenue growth.
- Research updates suggest significant upside to consensus price targets, drawing renewed investor interest in the stock.
- The move marks a sharp multi-day rally from early-June lows, with the stock significantly outperforming the flat broader market.